Table 2.
Category | All studies N = 108 (%) |
>50% African American N= 10 |
>50% Hispanic N= 19 |
>50% Asian N = 4 |
>50% Non-Hispanic White N=49 |
---|---|---|---|---|---|
Number racial/ethnic groups | |||||
More than one group | 84 (78) | 7 (70) | 7 (37) | 0 | 48 (98) |
One group | 18 (17) | 3 (30) | 12 (63) | 4 (100) | 1(2) |
Not documented | 6(5) | ||||
Size of study (N) | |||||
1–150 | 21 (19) | 4(40) | 8 (42) | 2(50) | 5(10) |
151–500 | 35 (32) | 4(40) | 7 (37) | 1(25) | 14 (29) |
501–1,000 | 10(9) | 0 | 2(11) | 1(25) | 5(10) |
1,001–10,000 | 23 (21) | 2(20) | 1(5) | 0 | 12 (25) |
>10,001 | 14 (13) | 0 | 0 | 0 | 10 (20) |
No documentation | 5(5) | 1(5) | 0 | 3(6) | |
Language used in study | |||||
English | 61 (56) | 9(90) | 0 | 1(25) | 35 (71) |
Bilingual | 27 (25) | 0 | 19 (100) | 2(50) | 3(6) |
>2 languages | 6(6) | 0 | 0 | 0 | 1(2) |
Not documented | 14 (13) | 1(10) | 0 | 1(25) | 10 (20) |
Location of study in the U.S. | |||||
North East | 10(9) | 2(20) | 1(5) | 2(50) | 3(6) |
Midwest | 13 (12) | 2(11) | 9(18) | ||
South | 11 (10) | 4(40) | 2(11) | 4(8) | |
West | 31 (29) | 13 (68) | 1(25) | 11 (22) | |
National | 39 (36) | 3 (30) | 1(5) | 1(25) | 21 (43) |
No documentation | 4(4) | 1(10) | 1(2) | ||
Type of study design | |||||
Primary data collection | 75 (69) | 8 (80) | 17 (89) | 3(75) | 31 (63) |
Secondary database analysis | 32 (30) | 2(20) | 2(11) | 1(25) | 18 (37) |
Not specified | 1(1) | ||||
Type of publication | |||||
Biomedical Medicine Journal | 42 (39) | 6(60) | 7 (37) | 1(25) | 22 (46) |
CAM journal | 27 (25) | 1(10) | 4(21) | 2(50) | 10 (20) |
Pharmacy journal | 14 (13) | 3(16) | 7(14) | ||
Nursing journal | 7(6) | 2(20) | 3(16) | 2(4) | |
Other* | 18 (17) | 1(10) | 2(10) | 1(25) | 8(16) |
Definition of herb | |||||
Herbal supplement | 32 (30) | 2(20) | 6(31) | 17 (35) | |
Herbal medicine | 13 (12) | 3(16) | 1(25) | 4(8) | |
Herbal remedy | 11 (10) | 3(16) | 1(25) | 5(10) | |
Medicinal plant | 16 (15) | 2(20) | 2(11) | 8(16) | |
Dietary supplement | 6(6) | 1(10) | 1(25) | 3(6) | |
Biologically based product | 11 (10) | 1(10) | 6(12) | ||
Not specified | 5(5) | 4(8) | |||
Other** | 14 (13) | 4(40) | 5(26) | 1(25) | 2(4) |
Documented Disclosure Rates | |||||
0–30 % | 10 (37) | 4(21) | 1(25) | 4(8) | |
31–40 % | 7(26) | 1(10) | 4(8) | ||
>41 % | 10 (37) | 1(5) | 7(14) | ||
Not documented | 81 | 9(90) | 14 (74) | 3(75) | 34 (69) |
Health conditions | |||||
Healthy/general health | 65 (60) | 5 (50) | 10 (53) | 4 (100) | 30 (61) |
HIV | 7(6) | 4(40) | 2(11) | ||
Diabetes | 7(6) | 5(26) | |||
Cancer | 10(9) | 1(10) | 7(14) | ||
Other*** | 19 (18) | 2(11) | 12 (25) | ||
Reasons of herb use | |||||
Overall Health Promotion | 17 (16) | 5 (50) | 3(16) | 10 (20) | |
Treatment for an ailment | 54 (50) | 4(40) | 13 (68) | 3(75) | 20 (41) |
Other**** | 12(11) | 1(25) | 7(14) | ||
Not specified | 25 (23) | 1(10) | 3(16) | 12 (24) | |
Education reported | |||||
Yes | 95 (88) | 9(90) | 18 (95) | 4 (100) | 45 (92) |
No | 13 (12) | 1(10) | 1(5) | 4(8) | |
Income reported | |||||
Yes | 69 (64) | 9(90) | 10 (53) | 2(50) | 33 (67) |
No | 39 (36) | 1(10) | 9(47) | 2(50) | 16 (33) |
Insurance reported | |||||
Yes | 42 (39) | 5 (50) | 5(26) | 3(75) | 18 (37) |
Not documented | 66 (61) | 5 (50) | 14 (74) | 1(25) | 31 (63) |
Public health journals, dental journals, and women’s health journals
Subject used own definition, CAM product, and home remedy
Glaucoma, arthritis, hypertension, depression, and menopause
Personal beliefs regarding herbs and conventional medications, and financial reasons